Concentra Group Holdings Parent, Inc. Income Taxes Disclosure
| For the Year Ended December 31, | |||||
| 2025 | |||||
| (in thousands) | |||||
Current income tax expense: | |||||
Federal | $ | 34,270 | |||
State and local | 8,752 | ||||
Total current income tax expense | 43,022 | ||||
Deferred income tax expense (benefit) | |||||
Federal | 10,340 | ||||
State and local | (2,384) | ||||
Total deferred income tax expense | 7,956 | ||||
Total income tax expense | $ | 50,978 | |||
| For the Year Ended December 31, | |||||||||||
| 2024 | 2023 | ||||||||||
| (in thousands) | |||||||||||
| Current income tax expense: | |||||||||||
| Federal | $ | 49,676 | $ | 50,911 | |||||||
| State and local | 14,135 | 13,262 | |||||||||
| Total current income tax expense | 63,811 | 64,173 | |||||||||
Deferred income tax benefit | (4,315) | (6,286) | |||||||||
| Total income tax expense | $ | 59,496 | $ | 57,887 | |||||||
| For the Year Ended December 31, | |||||||||||
| 2025 | |||||||||||
| Amount | Rate | ||||||||||
| Federal income tax at statutory rate | $ | 47,004 | 21.0 | % | |||||||
State and local income taxes, less federal income tax benefit(1) | 4,533 | 2.0 | |||||||||
Tax credits | (1,854) | (0.8) | |||||||||
Nontaxable or nondeductible items | |||||||||||
Limitation on officer’s compensation | 1,822 | 0.8 | |||||||||
Stock based compensation | 169 | 0.1 | |||||||||
Other permanent differences | 702 | 0.3 | |||||||||
Non-controlling interest | (1,351) | (0.6) | |||||||||
Other | (47) | (0.0) | |||||||||
| Effective income tax rate | $ | 50,978 | 22.8 | % | |||||||
For the Year Ended December 31, | |||||||||||
| 2024 | 2023 | ||||||||||
Federal income tax at statutory rate | 21.0 | % | 21.0 | % | |||||||
State and local income taxes, less federal income tax benefit | 4.6 | 4.2 | |||||||||
Permanent differences | 0.7 | 0.3 | |||||||||
Deferred income taxes — state income tax rate adjustment | 0.0 | (0.3) | |||||||||
Revision to prior years’ estimated taxes | 0.3 | 0.4 | |||||||||
Stock-based compensation | (0.0) | (0.5) | |||||||||
Non-controlling interest | (0.6) | (0.5) | |||||||||
Other | (0.3) | (0.7) | |||||||||
Effective income tax rate | 25.7 | % | 23.9 | % | |||||||
For the Year Ended December 31, | |||||
| 2025 | |||||
| (in thousands) | |||||
Federal | $ | 34,788 | |||
State | 11,122 | ||||
Total | $ | 45,910 | |||
For the Year Ended December 31 | |||||
| 2025 | |||||
(in thousands) | |||||
State | |||||
California | $ | 5,077 | |||
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (in thousands) | |||||||||||
| Deferred tax assets | |||||||||||
| Implicit discounts and adjustments | $ | 12,447 | $ | 10,970 | |||||||
| Compensation and benefit-related accruals | 21,420 | 21,017 | |||||||||
| Professional malpractice liability insurance | 7,135 | 6,872 | |||||||||
| Federal and state net operating loss and state tax credit carryforwards | 7,398 | 3,602 | |||||||||
| Interest limitation carryforward | 1,964 | 2,153 | |||||||||
| Stock awards | 522 | 142 | |||||||||
| Operating lease liabilities | 127,878 | 123,301 | |||||||||
| Research and experimental expenditures | 829 | 9,048 | |||||||||
| Other | 2,873 | 3,206 | |||||||||
| Deferred tax assets | 182,466 | 180,311 | |||||||||
| Valuation allowance | (2,693) | (2,618) | |||||||||
| Deferred tax assets, net of valuation allowance | $ | 179,773 | $ | 177,693 | |||||||
| Deferred tax liabilities | |||||||||||
| Depreciation and amortization | $ | (81,738) | $ | (80,947) | |||||||
| Operating lease right-of-use assets | (116,949) | (113,491) | |||||||||
| Other | (5,872) | (4,223) | |||||||||
| Deferred tax liabilities | (204,559) | (198,661) | |||||||||
| Deferred tax liabilities, net of deferred tax assets | $ | (24,786) | $ | (20,968) | |||||||
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (in thousands) | |||||||||||
Non-current deferred tax asset | $ | 24,120 | $ | 4,412 | |||||||
| Non-current deferred tax liability | (48,906) | (25,380) | |||||||||
Net deferred tax liability | $ | (24,786) | $ | (20,968) | |||||||
| State Net Operating Losses | Gross Valuation Allowance | ||||||||||
| (in thousands) | |||||||||||
| 2026 | $ | 1,262 | $ | 707 | |||||||
| 2027 | 831 | 541 | |||||||||
| 2028 | 220 | 220 | |||||||||
| 2029 | 983 | 672 | |||||||||
Thereafter through 2045 | 52,189 | 43,707 | |||||||||
Total | $ | 55,485 | $ | 45,847 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.